These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2015-003032-13 A 16 week PILOT Study to determine the Frequency of Suphonylurea-Associated Hypoglycaemia in older moderately frail patients with type 2 diabetes mellitus poorly controlled on metformin: an open label... not-yet-due
Ongoing 2015-005820-24 A randomized study to evaluate the efficacy of ingenol mebutate on actinic keratoses and field cancerization compared to cryotherapy Studio randomizzato per valutare l'efficacia di ingenolo mebutat... not-yet-due
Ongoing 2016-000490-20 Evaluation of efficacy, safety and patient¿s satisfaction of daylight photodynamic therapy (DL-PDT) in the treatment of actinic keratosis on the face and scalp and related field cancerization carried ... not-yet-due
Ongoing 2017-001024-21 innovative model for the eradication of HCV in a population at high risk of irregular immigrants and low-income refugees modello innovativo per l'eradicazione dell'infezione da HCV in una popolazio... not-yet-due
Ongoing 2017-004195-58 CAVE (Cetuximab-AVElumab) lung: A single arm phase II clinical study of the combination of avelumab plus cetuximab in the second line treatment of metastatic non small cell lung cancer (NSCLC) patient... not-yet-due
Ongoing 2017-004392-32 CAVE (Cetuximab-AVElumab) mCRC: A single arm phase IIclinical study of the combination of avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients. CAVE (Cetuximab... not-yet-due
Ongoing 2017-004663-12 Geriatric outcomes among older Type 2 diabetic patients treated with DPP4 inhibitors or glinides: focus on cognitive functioning (GOOD-WP3) Outcomes geriatrici in pazienti anziani affetti da diabet... not-yet-due
Ongoing 2018-001600-12 Phase II randomized study evaluating the efficacy of panitumumab (VEctibix) and Trifluridine-Tipiracil (LOnsurf) in pretreated RAS wild type metastatic colorectal cancer patients: the VELO trial St... not-yet-due
Ongoing 2019-000674-28 A phase II trial evaluating the activity of cabozantinib in pre-treated patients with metastatic colorectal cancer (mCRC). Studio di fase II per valutare l'attività di cabozantinib in pazienti pret... not-yet-due
Ongoing 2019-002977-69 Durability of combination of insulin and GLP-1 receptor agonist or SGLT-2 inhibitors versus basal bolus insulin regimen in type 2 diabetes: a randomized controlled trial Durability della terapia di... not-yet-due
Ongoing 2020-002940-22 EFFECTS OF THE GLP-1 RECEPTOR AGONIST LIRAGLUTIDE ON LOWER LIMB PERFUSION IN PEOPLE WITH TYPE 2 DIABETES AND PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAL Effetti dell’agonista recettori... not-yet-due